COMMUNIQUÉS West-GlobeNewswire

At RSNA 2024, Konica Minolta Healthcare Introduces DR Solutions Designed to Optimize Workflows, Enhance Visualization and Manage Department Resources to Help Radiologists Build Intelligent Connections

01/12/2024 - 14:00

For the fourth consecutive year, studies evaluating the expanding clinical utility of Dynamic Digital Radiography are part of the RSNA Scientific Sessions WAYNE, N.J., Dec. 01, 2024 (GLOBE NEWSWIRE) -- Konica Minolta [...]

RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai's Platform to Develop a New AI Control System for Clinical AI Performance and Safety

01/12/2024 - 13:00

DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation to ensure AI scalability, performance monitoring, and safety, [...]

Siemens Healthineers and RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™

01/12/2024 - 18:00

Siemens Healthineers and DeepHealth have signed a letter of intent to create AI-powered SmartTechnology™ to improve patient experience and operational efficiency in ultrasound. The collaboration aims to facilitate [...]

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

01/12/2024 - 17:05

– Les données intermédiaires d’une étude de phase II portant sur le pétosemtamab administré à une dose de 1 500 mg en monothérapie continuent de démontrer une activité cliniquement significative dans le traitement de 2 [...]

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

01/12/2024 - 17:05

– Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC – Conference call on Saturday, Dec. 7 at 9:00 a.m. ET to discuss full data set UTRECHT, The [...]

Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024

01/12/2024 - 16:00

December 1, 2024 Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading [...]

Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24

01/12/2024 - 15:00

December 1, 2024 Philips' intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely position the company to drive precision imaging for a greater number [...]

Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update

30/11/2024 - 02:40

All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company [...]

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

29/11/2024 - 22:30

BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease [...]

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

29/11/2024 - 22:25

BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today [...]

CorVel Announces Retirement of V. Gordon Clemons

29/11/2024 - 19:30

FORT WORTH, Texas, Nov. 29, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announces V. Gordon Clemons is electing to retire as a member of the Company’s Board of Directors (the “Board”) and as Chairman of [...]

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29/11/2024 - 19:30

SAN FRANCISCO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]

PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

29/11/2024 - 19:05

PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received [...]

Fate Therapeutics Announces Leadership Transition

29/11/2024 - 19:05

Bob Valamehr, Ph.D. MBA, To Become President and CEO January 1, 2025 Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN DIEGO, Nov. 29, 2024 [...]

Apogee Therapeutics Announces Agenda for Virtual R&D Day

29/11/2024 - 19:00

SAN FRANCISCO and WALTHAM, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy [...]

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

29/11/2024 - 17:30

COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]

Narayana Health Issues Statement Regarding Spire Healthcare Group plc Under Rule 2.8 of the Takeover Code

29/11/2024 - 15:56

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]

CORRECTION: RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution

29/11/2024 - 15:43

SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer detection. The clearance enables RadNet’s DeepHealth and GE HealthCare collaboration to bring [...]

Eurobio Scientific : succès de l’OPA à l’issue de sa première période, réouverture de l’offre du 4 au 17 décembre

29/11/2024 - 15:30

Eurobio Scientific : succès de l’OPA à l’issue de sa première période, réouverture de l’offre du 4 au 17 décembre Paris, le 29 novembre 2024 – 15H30 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME) et EB [...]